CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Berg Aaron President and CEO | Shares withheld for taxes | −21,093 | $0.62 | $13K | 881,541 |
| 2025-01-31 | Berg Aaron President and CEO | Option exercise · Restricted Stock Unit | +34,566 | 0 | ||
| 2025-01-31 | Berg Aaron President and CEO | Option exercise · Restricted Stock Unit | +44,933 | 44,934 | ||
| 2025-01-31 | Berg Aaron President and CEO | Option exercise · Restricted Stock Unit | +38,667 | 77,333 | ||
| 2025-01-31 | Fishman Peter L. SVP, CFO | Option exercise | +8,400 | 56,562 | ||
| 2025-01-31 | Fishman Peter L. SVP, CFO | Shares withheld for taxes | −4,665 | $0.62 | $3K | 51,897 |
| 2025-01-31 | Fishman Peter L. SVP, CFO | Option exercise | +11,267 | 63,164 | ||
| 2025-01-31 | Fishman Peter L. SVP, CFO | Shares withheld for taxes | −6,258 | $0.62 | $4K | 56,906 |
| 2025-01-31 | Fishman Peter L. SVP, CFO | Option exercise | +36,667 | 93,573 | ||
| 2025-01-31 | Fishman Peter L. SVP, CFO | Shares withheld for taxes | −20,189 | $0.62 | $13K | 73,384 |
| 2025-01-31 | Fishman Peter L. SVP, CFO | Option exercise · Restricted Stock Unit | +8,400 | 0 | ||
| 2025-01-31 | Fishman Peter L. SVP, CFO | Option exercise · Restricted Stock Unit | +11,267 | 11,267 | ||
| 2025-01-31 | Fishman Peter L. SVP, CFO | Option exercise · Restricted Stock Unit | +36,667 | 73,333 | ||
| 2025-01-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +51,500 | 722,340 | ||
| 2025-01-30 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −28,382 | $0.62 | $18K | 693,958 |
| 2025-01-30 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Unit | +51,500 | 0 | ||
| 2025-01-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Unit | −51,500 | 0 | ||
| 2025-01-30 | Berg Aaron President and CEO | Option exercise | +51,500 | 856,880 | ||
| 2025-01-30 | Berg Aaron President and CEO | Shares withheld for taxes | −28,382 | $0.62 | $18K | 828,498 |
| 2025-01-30 | Berg Aaron President and CEO | Grant or award · Restricted Stock Unit | +51,500 | 0 |
Page 8 of 67 · 1,339 trades